Research Article
Association of Preoperative Serum Levels of CEA and CA15-3 with Molecular Subtypes of Breast Cancer
Table 2
Correlation between serum CEA, CA15-3, and CA125 levels and molecular subtypes in breast cancer.
| | Tumor marker | Luminal A () | Luminal B1 () | Luminal B2 () | Her-2+ () | Triple-negative () | value |
| | CEA (ng/ml) | | | | | | 0.0194 | | <5 | 213 (95.09) | 371 (96.61) | 117 (92.13) | 98 (89.91) | 114 (97.44) | | | ≥5 | 11 (4.91) | 13 (3.39) | 10 (7.87) | 11 (10.09) | 3 (2.56) | | | CA15-3 (U/ml) | | | | | | 0.0007 | | <25 | 216 (96.43) | 371 (96.61) | 114 (89.76) | 103 (94.50) | 103 (88.03) | | | ≥25 | 8 (3.57) | 13 (3.39) | 13 (10.24) | 6 (5.50) | 14 (11.97) | | | CA125 (U/ml) | | | | | | 0.2605 | | <35 | 213 (95.09) | 363 (94.53) | 121 (95.28) | 104 (95.41) | 105 (89.74) | | | ≥35 | 11 (4.91) | 21 (5.47) | 6 (4.72) | 5 (4.59) | 12 (10.26) | |
|
|
Luminal B1: ER+/PR+, Her-2 negative; Luminal B2: ER+/PR+, Her-2 positive; Her-2+: Her-2 overexpression. and . |
